Last quarter (Q ), QuantRx Biomedical's total revenue was $―, a decrease of ― from the same quarter last year. In Q, QuantRx Biomedical's net income was $-61.17K. See QuantRx Biomedical’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	-	-	-	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	-	-	$ 10.50K	-	-	-
Gross Profit	-	-	$ -10.50K	-	-	-
Operating Expense	$ 44.32K	$ 43.38K	$ 50.12K	$ 201.74K	$ 235.88K	$ 165.17K
Operating Income	$ -44.32K	$ -43.38K	$ -60.62K	$ -201.74K	$ -235.88K	$ -165.17K
Net Non Operating Interest Income Expense	$ -216.19K	$ -216.66K	$ -216.72K	$ -198.18K	$ -231.03K	$ -245.41K
Other Income Expense	-	$ -500.00K	$ -24.61K	$ -222.00K	$ -269.94K	$ 1.28M
Pretax Income	$ -260.51K	$ -260.04K	$ -252.73K	$ -621.92K	$ -736.85K	$ 869.14K
Tax Provision	-	-	-	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -260.51K	$ -260.04K	$ -252.73K	$ -621.92K	$ -736.85K	$ 869.14K
Basic EPS	$ >-0.01	-	-	$ -0.01	$ -0.01	$ 0.01
Diluted EPS	$ >-0.01	$ -0.01	$ -0.01	$ -0.01	$ -0.01	$ 0.01
Basic Average Shares	$ 314.79M	$ 78.70M	$ 78.70M	$ 78.70M	$ 78.70M	$ 78.70M
Diluted Average Shares	$ 314.79M	$ 78.70M	$ 78.70M	$ 78.70M	$ 78.70M	$ 130.44M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 44.32K	$ 43.38K	$ 60.62K	$ 201.74K	$ 235.88K	$ 165.17K
Net Income From Continuing And Discontinued Operation	$ -260.51K	$ -260.04K	$ -252.73K	$ -621.92K	$ -736.85K	$ 869.14K
Normalized Income	$ -118.53K	-	-	$ -399.92K	$ -366.65K	$ -405.90K
Interest Expense	$ 108.36K	-	-	$ 198.18K	$ 232.17K	$ 245.41K
EBIT	$ -44.32K	$ -43.38K	$ -36.01K	$ -423.74K	$ -504.68K	$ 1.11M
EBITDA	$ -44.32K	$ -43.38K	$ -36.01K	$ -423.74K	$ -504.68K	$ 1.13M

Currency in USD

QuantRx Biomedical Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing